Elise Solberg

WS Audiology Strengthens Commitment to Innovation with New R&D Centre of Excellence in Hyderabad

2 min read

WS Audiology Strengthens Commitment to Innovation with New R&D Centre of Excellence in Hyderabad

WS Audiology (WSA), a global leader in the hearing aid industry, today inaugurated its new Research and...

Read More

German car manufacturer visits HoneyNaps, a South Korean sleep tech company, to develop new automotive healthcare applications

3 min read

German car manufacturer visits HoneyNaps, a South Korean sleep tech company, to develop new automotive healthcare applications

Amid the rapid advancement in automobile healthcare and digital healthcare markets, global car manufacturers are racing to...

Read More

Pharmactive Presents Affron® Saffron Gummies and Aged Black Garlic

1 min read

Pharmactive Presents Affron® Saffron Gummies and Aged Black Garlic

Catering to the world of natural wellness, Pharmactive Biotech Products, SLU will showcase two premier clean-label botanical...

Read More

Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Switzerland

2 min read

Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Switzerland

Bavarian Nordic A/S (OMX: BAVA) announced today that the Swiss Agency for Therapeutic Products, Swissmedic, has approved...

Read More

Venus Remedies awarded its first incentive of Rs.7.50 cr. under PLI scheme

2 min read

Venus Remedies awarded its first incentive of Rs.7.50 cr. under PLI scheme

Venus Remedies Ltd, one of India’s leading manufacturers of generic drugs, has been awarded its first disbursement...

Read More

Signia’s Campaign: A Beacon for Hearing Health Advocacy

1 min read

Signia’s Campaign: A Beacon for Hearing Health Advocacy

Embarking on a mission to dismantle the barriers surrounding hearing health, Signia this month launches a pioneering...

Read More

Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application for Novel MICA/B Antibody, CLN-619, for Relapsed/Refractory Multiple Myeloma

1 min read

Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application for Novel MICA/B Antibody, CLN-619, for Relapsed/Refractory Multiple Myeloma

Cullinan Oncology, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on modality-agnostic targeted oncology therapies, today announced the U.S. Food...

Read More

SOUTH MUMBAI BASED 60+ YEAR OLD CMJ JAIN Hospital introduces IN A FIRST AS A CHARITABLE HOSPITAL, robotic surgery on SSI Mantra platform

2 min read

SOUTH MUMBAI BASED 60+ YEAR OLD CMJ JAIN Hospital introduces IN A FIRST AS A CHARITABLE HOSPITAL, robotic surgery on SSI Mantra platform

CMJ Hospital, a beacon of healthcare for the poor & needy in Girgaon, Mumbai, with a legacy...

Read More

Johnson & Johnson’s nipocalimab granted U.S. FDA Breakthrough Therapy Designation for the treatment of individuals at high risk for severe hemolytic disease of the fetus and newborn (HDFN)

2 min read

Johnson & Johnson’s nipocalimab granted U.S. FDA Breakthrough Therapy Designation for the treatment of individuals at high risk for severe hemolytic disease of the fetus and newborn (HDFN)

Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy...

Read More

Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, and Innovative Therapeutics through a Systems Biology Approach

2 min read

Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, and Innovative Therapeutics through a Systems Biology Approach

Yiviva, a clinical-stage, platform biotechnology company developing systems biology medicines to treat aging-related diseases, signed a memorandum...

Read More